Abstract
Pulmonary biogenic amine clearance is a carrier-mediated drug sensitive process associated with uptake into endothelial cells and subsequent metabolism by monoamine oxidase and other enzymes. Its function seems to be maintenance of arterial circulatory homeostasis by biochemically regulating circulating vasoactive hormones. Numerous pulmonary pathologic conditions are associated with alterations in these functions. However, a more precise physiologic role remains to be defined. Areas for further research include: 1. Comparative studies on the ability of endothelium from extrapulmonary and pulmonary vasculatures to extract and metabolize vasoactive amines and other humoral substances. This work must be done both in intact animals and in isolated cultured endothelium derived from organ microvasculatures. 2. Study of factors (e.g. steroids, development, etc) that may regulate pulmonary metabolic functions. 3. Measurements in humans under various clinical conditions. To this end, indicator dilution estimates and transpulmonary gradients have provided intriguing promise of means to assess endothelial metabolic functions in both normal and injured lung.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
